2023 Q4 CC Shoutbox transcript

[liane]

esstan2001: tks Liane a few seconds ago
x
liane: Thanks All! Great call! less than a minute ago
x
esstan2001: don't enough patients understand CGM realtime is so much more important than A1C? less than a minute ago
x
Chris-C: Good luck everyone! 1 minute ago
x
lookforgrowth: There appears to be respect for the long term shareholders. 1 minute ago
x
castlerockchris: Showing they know the market when it comes to PEDs 2 minutes ago
x
celo: Good overview of the pediatric study 2 minutes ago
x
Chris-C: Agreed lookforgrowth. 2 minutes ago
x
lookforgrowth: As an owner of several biotech and small tech companies, I am very impressed with the degree of fiscal responsibility that is being displayed. It is not just above spend, spend, spend and everything will be alright, but instead a sound fiscal plan/ 2 minutes ago
x
sayhey24: afrezza on top of the pump won't get insurance coverage 3 minutes ago
x
runner: Yes, crystal clear on this call. 3 minutes ago
x
Chris-C: Bravo MC for doing a great job over the past year. He has been much maligned, and is not perfect, but he has grown into the role over the years, IMO. 3 minutes ago
x
sayhey24: if nothing else MC got a new phone so we can hear him on the call 5 minutes ago
x
alethea: IMHO MNKD stock-price will be a multi-bagger from this point on. It may take weeks, months or even a year or two. But once MNKD gets past the Convertible Debt (Dec 2026?) it is inevitable. 5 minutes ago
x
celo: 25 different possible buyers of the 1% 6 minutes ago
x
Chris-C: Does this guy know that Al Mann passed many years ago? 7 minutes ago
x
esstan2001: although I am being critical, def one of the best calls over the past decade. 7 minutes ago
x
sayhey24: MNKD-501 not much has been said about this 7 minutes ago
x
alethea: There have never been this many analyst questions. MNKD has never before in such a position of strength. 8 minutes ago
x
Chris-C: Pretty detailed and complex call for most investors, especially those who look at "bottom line" revenues. 9 minutes ago
x
alethea: Anyone carefully listening to this call and who has followed MNKD for multiple years should easily understand how vast the progress made by MNKD during the last few years. 10 minutes ago
x
sayhey24: best analyst coverage in a long time 10 minutes ago
x
castlerockchris: I Don't put much faith in after hours trading, but it sure seems like the price for the remainder of the session is pegged to $3.9. hopefully some volume will come in at the open and drive the price up some more. 10 minutes ago
x
celo: Analyst don't understand share price 11 minutes ago
x
biffn: I can’t remember hearing this many questions in the last five or six years. 11 minutes ago
x
Chris-C: Wow. A whole army of analysts this time! 12 minutes ago
x
celo: Yeah he didn't answer chris 12 minutes ago
x
Chris-C: Good answer, MC. The comparisons I've seen all suggest that Tyvaso DPI is superior to the LQDA product. 13 minutes ago
x
sayhey24: TYVASO DPI growth? 13 minutes ago
x
sayhey24: what did UTHR predict Tyvaso DPI to be? 14 minutes ago
x
celo: ohh good question 15 minutes ago
x
castlerockchris: Orin, Orin, Orin, ask a question and give him the out to not answer... 15 minutes ago
x
sayhey24: BP wants afrezza stopped and PBMs are doing the job for them 15 minutes ago
x
cretin11: trying to go it alone has been a misguided strategy 17 minutes ago
x
sayhey24: watch Ginger's video - even she got denied for insurance 17 minutes ago
x
esstan2001: I told a T2 about it; went to his endo and got the exubera cancer story from the clown. 17 minutes ago
x
celo: PROVEN 18 minutes ago
x
celo: not if it's PROVENT to be the best product for patients say 18 minutes ago
x
sayhey24: growing afrezza is easy - address the cost 19 minutes ago
x
castlerockchris: Love that the analysts seem to have a lot of interest in MNKD101. Maybe that will lead to better valuation on that line as we move forward. 19 minutes ago
x
alethea: Remember when there simply were not any analysts with any questions? My oh my that seems to have changed. 19 minutes ago
x
esstan2001: please figure how to grow Afrezza 19 minutes ago
x
esstan2001: A + GPL's ->good 20 minutes ago
x
esstan2001: IH3- conversion does determination... pump titration- feels controls / design good; not targeting supeiority 20 minutes ago
x
sayhey24: Finally - having a trial to add afrezza to the GLPs 20 minutes ago
x
celo: make the data of the phase 4 as good as possible 21 minutes ago
x
Chris-C: agreed celo... 21 minutes ago
x
celo: Smart using a small trial to optimize the big trial 22 minutes ago
x
Chris-C: Nice that after 31 years MNKD is learning how to optimize the benefit of Afrezza. 22 minutes ago
x
cretin11: same here esstan 23 minutes ago
x
sayhey24: What happened to INHALE-2? 23 minutes ago
x
esstan2001: i hope Bill had high level input into trial design based on vdex 23 minutes ago
x
alethea: To say MNKD is creeping along is simply NOt correct. MNKD's situation has never been better. 23 minutes ago
x
Chris-C: Overall I'd say the best call ever. A bit of complexity but hopefully the investor reps got it. 24 minutes ago
x
cretin11: good Q cjc04 24 minutes ago
x
liane: Chris-C Nontuberculous Mycobacteria (NTM) 24 minutes ago
x
cjc04: Can “they” keep the sp under $5.21 til 2026 ? 24 minutes ago
x
alethea: (con'td) the entire call is full of positives. 25 minutes ago
x
cjc04: it will not be paid early, and it it will be paid in 2026 with cash and/or stock depending on stock price. 25 minutes ago
x
celo: 2.5% interest rate says not to pay the 230 million until its due 25 minutes ago
x
alethea: Earnings are increasing in a Big way. Even Afrezza has 27% growth. MNKD 101 and 201 sound like they are on a very sound track to succeed. Cash is good. 33M Midcap debt will be retired in a few months. The convertible debt is at 2.5%. The entire call 25 minutes ago
x
Chris-C: Good to see MidCap debt is being discharged. 25 minutes ago
x
cretin11: right 26 minutes ago
x
cjc04: The question about paying the $230m in convertible notes is answered. 26 minutes ago
x
sayhey24: At least now we are paying Irl Hersh to represent MNKD - thats a positive 27 minutes ago
x
wmdhunt: Need to payoff MidCon to get rid of their shorting against their positions. Need to dry up shorts somehow. 27 minutes ago
x
Chris-C: MNKD 101 is targeted toward patients with which bacterial condition(s)? 27 minutes ago
x
cretin11: correct sayhey it's not soaring, but at least creeping along, it could be worse. 27 minutes ago
x
alethea: Hang on to your long positions folks. It's going to take a while but a large increase is stock price is inevitable. 29 minutes ago
x
sayhey24: How is it soaring - this is pretty much the same presentation from last quarter 29 minutes ago
x
castlerockchris: WOW, Dry powder MNKD 101!!! 29 minutes ago
x
celo: dry powder for early stage? 29 minutes ago
x
cretin11: mc tries his best. i'm optimistic mnkd can survive his tenure. lower expectations than we had before, but hopefully the slow growth will eventually snowball in a good way. 29 minutes ago
x
runner: I'm with you, Alethea! 30 minutes ago
x
caesar: Focus on future earnings. Took years to setup in a Doggy Dog marketplace.... 30 minutes ago
x
alethea: Not only is MNKD moving in a positive direction, it is indeed SOARING. This is really a lot of fun. 30 minutes ago
x
sayhey24: Al would have broken through the wall. MC is still a TBD 30 minutes ago
x
esstan2001: Al would have broken out of the paradigm by now. MC seems boxed in 31 minutes ago
x
cretin11: agree chris. it's on him to rectify the market perception (which he is a big reason for unfortunately). i think we are at least moving in a positive direction. 32 minutes ago
x
alethea: Last quarter's call was GOOD. This quarter's call is FANTASTIC. This is easily the best I have ever felt about MNKD as an investment. 32 minutes ago
x
sayhey24: MC is correct. My concern is he now has Stockholm Syndrome and is willing to go along with what PBMs will give him 33 minutes ago
x
Chris-C: MC seems like he feels market treats his company unfairly. Possibly, but it's about history and performance. 34 minutes ago
x
wmdhunt: Complicated but sounds good! Got to get good results on trials. 34 minutes ago
x
cretin11: if they were it would certainly be mentioned 35 minutes ago
x
lookforgrowth: Agreed about the valuation. If we could just get it above $5.00 and have it hold for an extended period, we would get a lot more analyst coverage. 35 minutes ago
x
sayhey24: No V-Go user is changing to afrezza. They are like oil and water 35 minutes ago
x
cretin11: it doesn't sound like vgo has brought us any new afrezza users 36 minutes ago
x
celo: yes lookingforgrowth' 36 minutes ago
x
cretin11: mc's presentation/delivery is almost average today, which is encouraging as it's a huge improvement from before 36 minutes ago
x
Chris-C: I wondered the same thing about V-go 36 minutes ago
x
lookforgrowth: I always thought that acquiring v-go was more about additional Afrezza exposure than longer term v-go revenue. 37 minutes ago
x
akemp3000: This company is undervalued. 37 minutes ago
x
BlueCat: prescribers? 38 minutes ago
x
blaz: There we go VGO - brought us a couple a thousand new subscribers 38 minutes ago
x
lookforgrowth: Are any of the v-go users switching to Afrezza? 38 minutes ago
x
esstan2001: really sounds like the board must have a prove it to me attitude regarding Afrezza regarding results vs any marketing spend 39 minutes ago
x
BlueCat: vgo seemed to be the only flat note so far .... 39 minutes ago
x
cretin11: sayhey was right about v-go 40 minutes ago
x
cretin11: paying off midcap 41 minutes ago
x
sayhey24: We finally got "label change" on a slide 42 minutes ago
x
esstan2001: ramping investment spend along with increasing revs... evaluate marketing spend upon seeing inhale trial results 45 minutes ago
x
Chris-C: Not impressed with Vgo 48 minutes ago
x
runner: One/Two punch expected this year from the trials. 55 minutes ago
x
esstan2001: IH3 going against pumps 57 minutes ago
x
sayhey24: afrezza finally made the T2 market segment in years on a slide 57 minutes ago
x
runner: Fewer dropouts in pediatric trials compared to previous trials. 58 minutes ago
x
esstan2001: IH-3 dosing plus CGM 58 minutes ago
x
cretin11: hopefully he has been listening to Bill 59 minutes ago
x
esstan2001: pedi appvl 2025 59 minutes ago
x
sayhey24: afrezza is a prandial insulin 59 minutes ago
x
Chris-C: So they are marketing Afrezza as a prandial insulin? about an hour ago
x
celo: People don't want slow acting insulin in a world that moves this fast about an hour ago
x
Chris-C: Still tweaking the workforce... about an hour ago
x
Chris-C: Not a bad increase in net revenue! about an hour ago
x
sayhey24: V-Go did not make the 1st slide about an hour ago
x
akemp3000: An exceptional opening line! about an hour ago
x
cretin11: good ER so they should be eager to roll with the call about an hour ago
x
boca1girl: Hi everyone about an hour ago
x
lookforgrowth: The fits the calmness in the last few earnings. Let's hope we hear more good news on the call. about an hour ago
x
BlueCat: Lift off! about an hour ago
x
cretin11: so soothing. and the clarity is exceptional about an hour ago
x
parrerob: Ciao everybody about an hour ago
x
BlueCat: And its ..... nice acoustic guitar music.

[BD]

Wow, that’s about 5 times longer than the shoutbox script has been in ages. There’s life in the old board yet 🎉🎉

[prcgorman2]

In the old days, everybody would have had a cigarette after that performance.

[runner]

…and a few Martinis.

Me, I’m celebrating with a burrito and a beer!

[radgray68]

Wow, we've gone from the usual 25-30 minutes to an hour and 8 minutes. Doubled, like our revenue. Tee Hee.